Background: Depressive symptoms have been linked with insulin resistance in middle-aged and elderly populations. A strong relationship between peripheral insulin resistance and glucose homeostasis imbalance has been well established in previous studies. The role of serum fructosamine and fasting blood glucose (FBG) in elevating glucose homeostasis has been documented in the literature.
Objectives: The aim of the study was to examine the association of serum fructosamine and FBG with major depressive disorder (MDD).
Material And Methods: The study analyzed the clinical characteristics and biochemical parameters of 305 patients with MDD and 312 healthy individuals.
Results: Serum concentrations of lipoprotein-cholesterol (HDL-C), total protein (TP) and creatinine (Cr) were found to be significantly different between the two groups. Serum fructosamine and fasting blood glucose (FBG) concentrations were high in patients with MDD compared with healthy individuals (2.3 ± 0.26 vs. 2.1 ± 0.27, p = 0.018; 4.7 ± 0.45 vs. 4.5 ± 0.45, p < 0.001). The levels of serum fructosamine and FBG were also significantly higher in patients with MDD when all participants were stratified by gender. Age was found to be positively correlated with FBG, serum fructosamine and Cr (r = 0.203, p < 0.001; r = 0.129, p = 0.025; r = 0.129, p = 0.024), and negatively correlated with TP (r = -0.114, p = 0.047) in patients with MDD. However, there were no correlations between age and FBG, serum fructosamine or Cr in the healthy controls. In a multivariate logistic regression analysis, increased serum fructosamine and FBG concentrations were positively associated with MDD independently of age and gender, after adjustment for age and potential confounding factors (OR = 6.313, CI95 %:2.953-13.393, p < 0.001; OR = 2.251, CI95 %: 1.464-3.462, p < 0.001).
Conclusions: The study results suggest that increased serum fructosamine and FBG concentrations are associated with depressive conditions, which may influence glucose metabolism and impair glucose homeostasis in patients with MDD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.17219/acem/63023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Menaquinone-7 and its therapeutic potential in type 2 diabetes mellitus based on a Zucker diabetic fatty rat model.
Heliyon
December 2024
Institute of Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Nuremberg General Hospital, Paracelsus Medical University, Prof. Ernst Nathan Str. 1, 90419, Nuremberg, Germany.
Background: Type 2 diabetes mellitus (T2DM) is marked by insulin resistance, low grade chronic inflammation, and endothelial dysfunction. Vitamin K2, especially menaquinone-7 (MK-7), might delay T2DM progression and alleviate its consequences. Hence, this study evaluated the effects of MK-7 on serum and urine markers of diabetes in an animal model of T2DM.
View Article and Find Full Text PDFFructosamine as an Indicator for Glycemic Control in the Veteran Community.
Mil Med
December 2024
Department of Surgery, Podiatric Surgery, Stony Brook University Hospital, Stony Brook, NY 11794, USA.
Objective: Glycemic monitoring via Hemoglobin A1(HbA1c) proves to be inaccurate when a patient is diagnosed with a hemoglobinopathy/erythrocyte disorder. Moreover, any acute changes of glycemic intake within 6 weeks of blood sampling have been noted to impart a greater effect on HbA1c than the remaining days of the supposed overall 3-to-4-month average of glycemic control. Fructosamine, an alternative to HbA1c, allows physicians to analyze glycemic control in the presence of an underlying hemoglobinopathy/erythrocyte disorder.
View Article and Find Full Text PDFGlycated haemoglobin and serum fructosamine concentrations in sick, non-diabetic dogs receiving oral prednisolone.
Vet Rec
December 2024
Companion Animal Clinic, School of Veterinary Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Background: Glucocorticoids have been associated with an increased risk of developing diabetes mellitus (DM) in dogs. Glycated haemoglobin (HbA1c) and serum fructosamine have been scarcely studied in dogs receiving glucocorticoid therapy. The aim of this study was to evaluate HbA1c and fructosamine in non-diabetic dogs receiving oral prednisolone.
View Article and Find Full Text PDFThe clinical potential of 1,5-anhydroglucitol as biomarker in diabetes mellitus.
Front Endocrinol (Lausanne)
November 2024
Center of Molecular Medicine, Department of Basic Medicine, Shu-Qing Medical College, Zhengzhou, Henan, China.
A crucial measure of diabetes management is to monitor blood glucose, which often requires continuous blood collection, leading to economic burden and discomfort. Blood glucose and glycated hemoglobin A1c serve as traditional indicators of glucose monitoring. But now glycated albumin, fructosamine, and 1,5-anhydroglucitol (1,5-AG) have been gaining more attention.
View Article and Find Full Text PDFAlcoholic ketoacidosis: confused diagnosis.
BMJ Case Rep
November 2024
Family Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
A woman in her 30s presented with a 3-day history of nausea, vomiting and abdominal pain. She was found to be in ketoacidosis with an elevated serum glucose level of 18.2 mmol/L (328 mg/dL).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!